Literature DB >> 17954616

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.

Elizabeth Bullitt1, Nancy U Lin, J Keith Smith, Donglin Zeng, Eric P Winer, Lisa A Carey, Weili Lin, Matthew G Ewend.   

Abstract

PURPOSE: To prospectively determine if magnetic resonance (MR) angiography can depict intracranial vascular morphologic changes during treatment of brain metastases from breast cancer and if serial quantitative vessel tortuosity measurements can be used to predict tumor treatment response sooner than traditional methods.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained for this HIPAA-compliant study. Twenty-two women aged 31-61 years underwent brain MR angiography prior to and 2 months after initiation of lapatinib therapy for brain metastases from breast cancer. Vessels were extracted from MR angiograms with a computer program. Changes in vessel number, radius, and tortuosity were calculated mathematically, normalized with values obtained in 34 healthy control subjects (19 women, 15 men; age range, 19-72 years), and compared with subsequent assessments of tumor volume and clinical course.
RESULTS: All patients exhibited abnormal vessel tortuosity at baseline. Nineteen (86%) patients did not exhibit improvement in vessel tortuosity at 2-month follow-up, and all patients demonstrated tumor growth at 4-month follow-up. Vessel tortuosity measurements enabled us to correctly predict treatment failure 1-2 months earlier than did traditional methods. Three (14%) patients had quantitative improvement in vessel tortuosity at 2-month follow-up, with drop out of small abnormal vessels and straightening of large vessels. Each of the two patients for whom further follow-up data were available responded to treatment for more than 6 months.
CONCLUSION: Study results established the feasibility of using MR angiography to quantify vessel shape changes during therapy. Although further research is required, results suggest that changes in vessel tortuosity might enable early prediction of tumor treatment response. (c) RSNA, 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17954616      PMCID: PMC2615672          DOI: 10.1148/radiol.2453061889

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Vessel tortuosity and brain tumor malignancy: a blinded study.

Authors:  Elizabeth Bullitt; Donglin Zeng; Guido Gerig; Stephen Aylward; Sarang Joshi; J Keith Smith; Weili Lin; Matthew G Ewend
Journal:  Acad Radiol       Date:  2005-10       Impact factor: 3.173

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.

Authors:  Elizabeth Bullitt; Nancy U Lin; Matthew G Ewend; Donglin Zeng; Eric P Winer; Lisa A Carey; J Keith Smith
Journal:  Med Image Comput Comput Assist Interv       Date:  2006

6.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

7.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

8.  Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice.

Authors:  E Bullitt; P A Wolthusen; L Brubaker; W Lin; D Zeng; T Van Dyke
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

9.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G C Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G J Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

10.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more
  20 in total

1.  Vascular tortuosity: a mathematical modeling perspective.

Authors:  Leith Hathout; Huy M Do
Journal:  J Physiol Sci       Date:  2012-01-18       Impact factor: 2.781

Review 2.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

3.  Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum.

Authors:  Ewelina Kluza; Jean-Paul J E Kleijnen; Milou H Martens; Dorit Rennspiess; Monique Maas; Cécile R L P N Jeukens; Robert G Riedl; Axel zur Hausen; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

Review 4.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

Review 5.  Normalization of the vasculature for treatment of cancer and other diseases.

Authors:  Shom Goel; Dan G Duda; Lei Xu; Lance L Munn; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

6.  Ultrasound imaging of breast tumor perfusion and neovascular morphology.

Authors:  Kenneth Hoyt; Heidi Umphrey; Mark Lockhart; Michelle Robbin; Andres Forero-Torres
Journal:  Ultrasound Med Biol       Date:  2015-06-24       Impact factor: 2.998

7.  A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Authors:  Rachel A Freedman; Elizabeth Bullitt; Lixian Sun; Rebecca Gelman; Gordon Harris; Jennifer A Ligibel; Ian E Krop; Ann H Partridge; Emily Eisenberg; Eric P Winer; Nancy U Lin
Journal:  Clin Breast Cancer       Date:  2011-06-22       Impact factor: 3.225

Review 8.  CNS metastases in breast cancer: old challenge, new frontiers.

Authors:  Nancy U Lin; Laleh Amiri-Kordestani; Diane Palmieri; David J Liewehr; Patricia S Steeg
Journal:  Clin Cancer Res       Date:  2013-12-01       Impact factor: 12.531

9.  Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years.

Authors:  Elizabeth Bullitt; Matthew Ewend; James Vredenburgh; Allan Friedman; Weili Lin; Kathy Wilber; Donglin Zeng; Stephen R Aylward; David Reardon
Journal:  Neuroimage       Date:  2008-12-06       Impact factor: 6.556

Review 10.  Targeting the vasculature of tumours: combining VEGF pathway inhibitors with radiotherapy.

Authors:  Chryso Kanthou; Gillian Tozer
Journal:  Br J Radiol       Date:  2018-09-05       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.